• pharma
  • pharmapharma

CONFERENCE

rss_Pharma.jpg...see all
5th Annual Smoking Cessation

5th Annual Smoking Cessation

Accelerating innovations and assessing new strategies

27th - 28th January 2011, BSG Conference Centre, London, UK

  1. Background Info
  2. Day 1
  3. Day 2
  4. Partners
  5. Past Papers
  6. Venue Info
Media Partners
  • PharmiWeb.com
  • BIOTECHNOLOGY EUROPE
  • Future Pharmaceuticals
  • InPharm
  • Pharma Connections Worldwide

Background Info

Key Speakers
• Raymond Hreiche, Regional Scientific Advisor, Pfizer
• Angela DeVeaugh-Geiss, Principal Clinical Research Scientist, GSK
• Mike Kelly, Public Health Director, National Institute for Health and Clinical Excellence (NICE)
• Raafat Fahim, President and CEO, Nabi Biopharmaceuticals
• Scott Bryson, Lead Specialist in Pharmaceutical Public Health, NHS
• Robert Walton, Professor of Primary Medical Care, Barts and The London School of Medicine and Dentistry
• Dave Clark, Campaigns and Policy officer, Action on Smoking and Health (ASH)
• Simon Gilbody, Professor of Psychological Medicine and Health Services, University of York

Smoking remains one of the biggest health threats in the world, causing 5.4 million deaths worldwide and 100,000 deaths in the UK each year. With governments and health organisations constantly warning of dangers of smoking, there’s never been more pressure on smokers to quit. Figures suggest that around 50% of quit attempts involve the use of smoking cessation aids, usually in the form of nicotine replacement therapy (NRT), purchased over the counter. Most unaided attempts are often not very successful.

There is a growing market for new, safe and more effective smoking cessation therapies. This will see the global smoking cessation products market increase with a CAGR of 5% during the period 2008-2024, with revenues increasing from $3504m in 2008, to $7347m by 2024, Visiongain predicts. Growth will be most noted in the emerging economies of Brazil, Russia, China and India (BRIC).

Having hosted four previous successful Smoking Cessation events, Visiongain is now preparing for its 5th Annual Smoking Cessation conference. This conference will feature key industry experts who will discuss the latest in anti-smoking therapies, examine the challenges in the smoking cessation market, and review current control policies and preventative measures.

Why you should attend this conference:
• Examine the current market potential for emerging anti-smoking products
• Hear the latest innovations in smoking cessation therapies
• Assess the health benefits of smoking cessation
• Understand the effects of smoking on the human body
• Identify novel therapeutic targets for smoking cessation products
• Review the latest in tobacco prevention and control policies
• Use this opportunity as a platform for future collaborations

Who should attend this conference?
VPs, Directors, Heads and Managers of:
• Smoking Cessation
• Anti-smoking Products
• Tobacco Risk/Control
• Tobacco Research
• Clinical Trials
• Clinical Pharmacology
• Pharmacotherapy
• Drug Delivery
• Research & Development
• Scientific Affairs
• Primary Care
• Respiratory
• COPD
• Therapeutics
• Drug Addiction
• Health Improvement
• Epidemiology
• Consumer Insights
• Outcomes Research
• Product Development
• Pricing
• Marketing/Sales
• Public Affairs/Branding/Advertising
• Regulatory Affairs

Members of:
• Pharma, Biotech & Healthcare Organisations
• Government - Department of Health, NHS PCTs
• Non-profit Organisations/Associations
• Advertising/Public Relations Bodies
• Hospitals 

Day 1

Day 1, Thursday 27th January 2011

09:00 Registration and refreshments

09:30 Opening address from the chair

09:40 Smuggling and smoking: reducing the harm caused by the illicit trade
• What is illicit tobacco - extent and nature of the problem
• The price of smuggling - impact of illicit sales on tobacco control policies
• The impact of smuggling on health inequalities
• Tackling the illicit trade - establishing an international illicit trade protocol and other initiatives

Dave Clark
Campaigns and Policy officer
Action on Smoking and Health (ASH)

10:20 Varenicline medical update: a special look at smokers with co-morbidities
• New clinical data in CV and COPD smokers
• Varenicline in real-life clinical practice
• Varenicline safety update

Raymond Hreiche
Regional Scientific Advisor
Pfizer

11:00 Morning refreshments

11:20 NicVAX; A promising aid to smoking cessation and long term abstinence
• Introduction: mortality, morbidity and health care burden of smoking
• The unmet medical need; inadequacy of current smoking cessation therapies
• NicVAX “proof of concept” and progress towards the objective

Raafat Fahim
President and CEO
Nabi Biopharmaceuticals

12:00 Presentation to be announced

Rob Horne
Professor of Behavioural Medicine
The School of Pharmacy, University of London

12:40 Networking lunch

13:40 Drugs for smoking cessation don’t work!!
• The high rate of patient relapse in smoking cessation would not be tolerated in other therapeutic categories
• How can the relapse rate to reduced?
• What are the implications for new product development?
• Will these initiatives work in developing markets?

Rick Stewart
Chairman & Chief Executive Officer
Extab Corporation

14:20 WHO perspective
• Tobacco epidemic
• The impact of the interventions
• Possible future measurements

15:00 Afternoon Refreshments

15:20 Product information, tailored programmes, social support? What smokers want when they go online?
• What is the cyber landscape for smokers?
• Do they talk to each other, and what do they say?
• How do you influence their decisions and help them change their behaviour?

Trevor van Mierlo
CEO
Evolution Health Systems

16:00 The relationship between tobacco and illnesses
• Tobacco as a risk factor for the development of major illnesses
• The impact of smoking on pre-existing conditions
• The role smoking cessation in prevention

16:40 Closing remarks from the chair

16:50 Networking drinks
Take your discussions further and build new relationships in a relaxed and informal setting 

Day 2

Day 2, Friday 28th January 2011

09:00 Registration and refreshments

09:30 Opening address from the chair

09:40 Helping people with severe mental illness to quit smoking: what works?
• The link between mental illness and smoking
• The lack of engagement with traditional NHS Stop Smoking Services
• ‘What works’ to help people with SMI to quit smoking?

Simon Gilbody
Professor of Psychological Medicine and Health Services
University of York

10:20 Genetic effects on smoking cessation and response to treatment
• Survey of research evidence to date
• Systematic overview and meta analysis of randomised trials
• Future directions for personalised treatment

Robert Walton
Professor of Primary Medical Care
Barts and The London School of Medicine and Dentistry

11:00 Morning refreshments

11:20 The HEAT is on: How community pharmacy contributes to national smoking cessation targets in Scotland
• Shifting the model of service provision from GPs to pharmacists - a 5 year journey
• Outcome assessment - factors facilitating and inhibiting success
• Comparative effectiveness of smoking cessation therapies in the context of this service model
• Partnerships for success - the importance of joint working within and beyond the NHS
• The way forward - horizon scanning for future opportunities

Scott Bryson
Lead Specialist in Pharmaceutical Public Health
NHS

12:00 The role of nicotine replacement therapy in combating a global epidemic
• The epidemiology of smoking – from adolescence to adulthood.
• Nicotine replacement therapy – dosage forms and indications.
• Novel products for smoking cessation? NRT in a changing environment.

Angela DeVeaugh-Geiss
Principal Clinical Research Scientist
GSK

12:40 Networking lunch

13:40 NICE’s guidance on quitting smoking
• The role of cessation services
• Smoking and pregnancy
• Future directions

Mike Kelly
Public Health Director
National Institute for Health and Clinical Excellence (NICE)

14:20 Examining the growing market in smoking cessation
• The current market scenario and expansion
• The emphasis on controls and greater awareness
• Government/NGO initiatives in the developing world
• The approach and strategy

Ashok Narasimhan
Managing Director
Zenara

15:00 Afternoon refreshments

15:20 Can we get any more out of NRT?
• Success rates
• Current limitations
• Future directions

16:00 Smoking cessation in BRIC:
• Prevalence of smoking in these countries
• Tobacco control and legislation
• How can smoking cessation services and products currently used in the West, be extended to these parts of the world?

16:40 Chair’s closing remarks

16:50 End of Conference 

Partners

Media Partners:

PharmiWeb.com
PharmiWeb.com is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. For further information please email: corporate@pharmiweb.com

BIOTECHNOLOGY EUROPE
BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the main goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit www.biotechnology-europe.com

Future Pharmaceuticals
Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries' top issues and the solutions top-tier vendors can provide. For further information, please visit www.futurepharmaus.com

InPharm
InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to InPharmjobs.com, Pharmafile and Pharmafocus. For further information please visit: www.In-Pharm.com

Pharma Connections Worldwide
Pharma Connections Worldwide® is the leading professional business networking website focused in the Pharmaceutical, Biotechnology and Life Sciences research industry. Our goal is to provide a conduit for delivery of premiere content coupled with the right clientele in order to facilitate business development opportunities among industry professionals responsible for making key decisions in a global marketplace. For further information please visit www.pharmaconnections.com

Enquiries

If you would like more information on the range of sponsorship or exhibition possibilities for visiongain's 5th Annual Smoking Cessation Conference, please contact:
Ronald Magali, +44 (0)20 7549 9934
ronald.magali@visiongainglobal.com
 

Past Papers

Speaker presentations are free to delegates. If you are unable to attend the event, the presentations are published two weeks after the event and are available to purchase. 

Venue Info

The visiongain event is to be held at BSG House, London. The address of the venue is:
BSG House, 226-236 City Road, London EC1V 2QY
Click for Google maps.

Directions to the venue:
The nearest airports are:

London/Heathrow - LHR
• By train: take the Heathrow Express to Paddington. Change onto the London Underground - Hammersmith & City Line (pink) to King’s Cross, change to the Northern Line (black) to Old Street
• By taxi: Approx. distance: 20 miles / 33KM. Approx. cost: GB£50.00. Approx. time: 1hour 20 mins

London/Gatwick - LGW
• By train: take the Gatwick express to Victoria. Change onto the London Underground - Victoria Line (light blue) to King’s Cross, change to the Northern Line (black) to Old Street.
• By taxi: Approx. distance: 35 miles / 56KM. Approx. cost: GB£60.00. Approx. time: 1hour 20 mins

London City – LCY
• By train: take the Docklands Light Railway to Bank station. Change onto the London Underground - Northern Line (black) to Old Street.
• By taxi: Approx. distance: 6 miles / 9KM. Approx. cost: GB£25.00. Approx. time: 45 mins
Please note these timings and prices are given only as an indication. During peak hours they are subject to increase.
If you wish to pre-arrange travel by taxi and prices with a local taxi company, Addison Lee can be contacted on +44 (0) 20 7387 8888

Eurostar St Pancras International
By train: Change onto the London Underground at King’s Cross – Northern Line (black) to Old Street.
By taxi: Approx. distance: 1.8 miles / 2.89 KM Approx. cost: GB £7.00 Approx. time: 5 minutes
Please note these timings and prices are given only as an indication. During peak hours they are subject to increase.

The nearest major train stations are:
• King’s Cross – take the London Underground - Northern line (black) to Old Street
• Liverpool Street – take the London Underground – Hammersmith & City (pink), Circle (yellow) or Metropolitan lines (maroon) to Moorgate. Change onto the Northern line (black) to Old Street
• Waterloo – take the London Underground – Jubilee line (grey) to London Bridge. Change onto the Northern Line (black) to Old Street

Walking from Old Street station:
Take exit 8 from the station and follow the green line on the floor to Moorfields Eye Hospital, continue on past there for 3-4 minutes, you will see a blue sign on the side of the building saying BSG. This is BSG House, 226-236 City Road.

Venue facilities include:
BSG House features wi-fi internet access and the possibility of using additional meeting rooms. Please contact visiongain for further information.

Local Accommodation:

Here are a list of recommended local hotels
Travelodge London City Road Hotel, 7-12 City Road, London, EC1Y 1AE, Tel: 0871 984 6333, Fax: 0207 628 2503, http://www.travelodge.co.uk/search_and_book/hotel_overview.php?hotel_id=340
Approximately a 10 minute walk to BSG House and close to Old Street tube station and Moorgate which is just 0.5 miles away. The hotel has a breakfast restaurant area and is close to a range of bars and restaurants with attractions including the Globe Theatre and St Pauls Cathedral close by.
Jury’s Inn Islington, 60 Pentonville Road, Islington, London N1 9LA. Tel: +44 (0) 207 282 5500
This hotel is a short journey, or 20-minute walk, away from the conference venue. It is a few minutes walk from Angel tube station and close to King’s Cross, and Euston stations. Also close by is Upper Street (Islington) which has many restaurants, cafes and bars. The rooms offer satellite TV, and internet connections. The hotel has both a bar and restaurant. Standard double room – Single occupancy £98, including breakfast £105, Double occupancy only £98 including breakfast £112. Call reservations on +44 (0) 207 282 5500 and quote Visiongain on booking. This offer is subject to availability.
Hilton London Islington, 53 Upper Street, Islington, London, N1 0UY Tel: +44 (0) 207 354 7700
Probably the furthest from the venue of all of our recommended hotels, but probably the most up-market of the local hotels. Close to Upper Street (Islington) which has plenty of dining and drinking options. Also nearby to Angel tube station and a short cab ride from King’s Cross. The hotel offers wi-fi and a business centre, and a restaurant and bar. Each guest room offers internet access, satellite TV channels and a desk.
London City Holiday Inn Express, 275 Old Street, London, EC1V 9LN Tel: +44 (0) 207 300 4300
Approximately a 10 minute walk to BSG House and close to Old Street tube station, this hotel offers a restaurant and a range of business services, including high-speed internet access in all rooms and the lobby area. The hotel is ideally located for the fashionable bars and restaurants of areas of Hoxton, Shoreditch and Clerkenwell.

The best to see in your host city:

Places to eat:
• Fifteen, 15 Westland Place, N1 7LP T: +44 (0)871 330 1515 – Italian/Fusion
• Carluccio’s Caffe, 305-307 Upper Street, N1 2TU, T: +44 (0) 207 359 8167 – Italian
• Hanoi Café, 98 Kingsland Road, E2 8DP, T: 020 7729 5610 – Vietnamese
• Isarn, 119 Upper Street, N1 1QP, T: 0207 424 5153 – Thai
• Moro, 34-36 Exmouth Market, EC1R 4QE, T: 020 7833 8336 - Spanish

Places to drink:
All of the bars listed do serve food during peak hours
• The Eagle, 2 Shepherdess Walk, City Road, London N1 7LB, T: +44 (0) 20 7553 7681
• Cantaloupe Bar, 35-42 Charlotte Street, London, EC2A 3PB T: +44 (0) 20 7613 4411
• Bavarian Beerhouse, 190 City Road London EC1V 2QH, T: +44 (0) 20 760 80 925
Also Upper Street in Angel Islington, just a short taxi ride away, has a large number of bars and restaurants offering a wide range of cuisine.

If you have the time:
St Pauls Cathedral (1 MI / 1.61 KM )
British Museum (1 MI / 1.61 KM )
Oxford Street * Great for shopping * (1.5 MI / 2.41 KM )
Tower of London (2 MI / 3.22 KM )
Tate Modern (2 MI / 3.22 KM )
London Eye (2 MI / 3.22 KM )
Westminster Abbey (2.5 MI / 4.02 KM )
Houses of Parliament (2.5 MI / 4.02 KM )

Please note: The information contained herein is intended for guidance purposes only. The responsibility to ensure accuracy of the details before visiting remains that of the individual. Visiongain can not be held responsible for any losses resulting from actions taken on the above information.